With over 120 years of experience and more than 17,000 employees in over 20 countries, Daiichi Sankyo is dedicated to discovering, developing, and delivering new standards of care that enrich the quality of life around the world.
In Europe, we focus on two areas: The goal of our Specialty Business is to protect people from cardiovascular disease, the leading cause of death in Europe, and help patients who suffer from it to enjoy every precious moment of life. In Oncology, we strive to become a global pharma innovator with competitive advantage, creating novel therapies for people with cancer.
Our European headquarters are in Munich, Germany, and we have affiliates in 13 European countries and Canada.
For our development and production site in Pfaffenhofen/Ilm we are seeking highly qualified candidates to fill the position:
Tech Management Lead (m/f/x) Drug Substance
The position:
The Tech Management Lead Drug Substance is responsible for the management of technol-ogy transfer of the manufacturing processes of drug substance (especially Antibody-Drug Conjugates) for investigational and commercial drugs to the sites of manufacture, both inter-nal and external to Daiichi Sankyo, until transition to routine manufacture.
The candidate is leading the Site Launch Team with its associated subteams. Accordingly, the candidate is responsible for executing the technology transfer in accordance with the established stand-ard processes to facilitate alignment of tech transfer and validation activities across the pro-jects for drug substance manufacturing, evaluates CMC risks for appropriate escalation, rec-ommends transition milestones and ensures a smooth transition of projects, recommends, and implements new technologies, as needed and supports Supply Chain Management with technical issues during routine commercial production.
Original Stellenanzeige mit Gehaltsinformation auf StepStone.de